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Abstract Objective To study expression of adenoviral-mediated Hath1-EGFP gene in the guinea pig co⁃
chlea after transfer through intact round window membrane(RWM), and to assess its effects on hearing.
Methods Twenty adult guinea pigs were used, of which: 12 were surgically inoculated with Ad-Ha⁃
th1-EGFP in the bony groove of round window niche, and 8 with artificial perilymph. Auditory brainstem
response(ABR) thresholds were determined in all animals before and 5 days after surgery. On post-sur⁃
gery day 5 and day 14, animals were sacrificed and whole mounts of cochlea and frozen sections were ex⁃
amined. Results ABR tests showed no significant change of hearing after the surgery. Strong fluorescence
staining in the cochleae was seen in Ad-Hath1-EGFP groups. The highest levels of gene expression were
seen in the post-surgery day 5 group with little decrease on post-surgery day 14.The contralateral co⁃
chlea and those in the control groups were free of fluorescence staining. Conclusion The transgenic Ha⁃
th1-EGFP can be effectively delivered into the inner ear through intact RWM, in an atraumatic manner.
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Introduction
As neurosensory cells in the mammalian auditory
system--cochlear hair cells can transduce sound
stimulation into electrical signals which are con⁃
veyed to CNS through acoustic nerve to maintain
normal hearing. However, many factors including
excessive sound stimulation, ageing，ototoxic
drugs and autoimmune diseases can induce irre⁃
versible damages of cochlear hair cells, resulting
in permanent sensorineural hearing loss. Previous
studies have demonstrated that although spontane⁃
ous replacement responses can be found in birds
and lower vertebrates after hair cells idamage，re⁃
generation of hair cells and recovery of hearing
function are yet to be found in the mature mamma⁃
lian cochlea 1. In recent years research reportes
concerning application of exogenous genes with in⁃
duction and differentiation-promoting functions
in the regeneration of adult mammalian inner ear
hair cells have challenged the conventional idea
that adult mammalian inner ear hair cells cannot
regenerate2. The delicate cochleas structure，poses
a difficult challenge effective yet safe transfer of
target genes into the cochlea without cochlear
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structure damage. The aim of this in vivo study is
to investigate the possibility of gene delivery
through the intact round window membrane using
an adenoviral vector system without cochlea struc⁃
ture damage in a guinea pig model. The results
from this study show significant levels of Ha⁃
th1-EGFP gene expression in the cochlea, and
may serve as a foundation for further study on in⁃
ner ear gene therapy.
1 Materials and methods
1.1 Material Recombination adenovirus with Ha⁃
th1 and enhanced green fluorescent protein vector
（Ad-Hath1-EGFP）3, 4 were provided by Prof.Gao
(Genentech USA )
1.２ Animals Randomly bred Hartley-strain guin⁃
ea pigs weighing 250-300 g were used in this
study. Twenty guinea pigs were randomly divided
into a control（n = 8）, and an experiment group
（n=12). The left ear served as the test ear .
1.3 Auditory brainstem response（ABR） Under gen⁃
eral anesthesia, a needle electrode was placed at
the vertex as the recording electrode, and another
two needle electrodes into both ears as the refer⁃
ence. The ground electrode was placed subcutane⁃
ously at the nose. Stimuli were Clicks（0.1 ms）,
1024 responses were superimposed bandpass-fil⁃
tered（80~3 000 Hz）, and then averaged on an Intel⁃
ligent Hearing System Smart EP2.22 system（IHS
USA）which was also used for analyzing the re⁃
cordings. ABR thresholds were determined via vi⁃
sual identification of reproducible responses with
descending click intensities at 10 dB steps. ABR
threshold were tested before and five days after
operative procedure for each animal.
1.４ Surgical procedures Under general anesthe⁃
sia, the tympanic bulla was opened, and the round
window niche exposed. A approximately 5ul
Ad-Hath1-EGFP（experiment group）or artificial
perilymph（control group）was injected into the
round window niche . To prevent immediate back⁃
flow of the viral suspension, the cannula was left
in place for 5 min following the inoculation. The
tympanic bulla then was closed with a muscle flap
and the incision closed with sutures.
1.5 Cochlear whole mount preparation Animals were
sacrificed 5 days or 14 days after surgery（3 ani⁃
mals from the experiment group, and 2 animals
from the control group）. Following decapitation
under deep anesthesia, the temporal bones were
quickly opened and the stapes removed. The
round window membrane and cochlear tips were
perforated using a fine needle. The cochlea was
gently perfused with 4% paraformaldehyde fixative
in 10mM phosphate buffered saline（PBS）, pH 7.4,
through the cochlea tip. The entire temporal bones
was immersed in the fixative for 2 hours and
rinsed in 10 mM PBS twice. The whole mount was
then examined under a fluorescence microscope.
1. ６ Frozen section preparation Three animals
from the experiment group and 2 from the control
group were sacrificed 5 days or 14 days after sur⁃
gery by decapitation under deep anesthesia. Both
temporal bones were removed and the fluid spac⁃
es of the inner ear perfused with 4% paraformalde⁃
hyde in phosphate buffer saline（PBS）. The speci⁃
mens were decalcified for 3 days in 10% EDTA,
cryo-protected in 30% sucrose for 24h and trans⁃
ferred into cryo-molds filled with OCT embedding
compound. The molds were vacuumed at low pres⁃
sure for 10 min, to remove trapped air. The speci⁃
men was kept in OCT at 4℃ for 24 h to for ade⁃
quate infiltration into the inner ear. It was appro⁃
priately aligned and, snap-frozen in liquid nitro⁃
gen for 0.5 min before sectioning. Sections（8 μm
thick）were cut on a Leica Cryomicrotom 2800. A
pproximately 200 serial sections were collected
from each ear onto electrostatic glass slides,
which were examined under a fluorescence micro⁃
scope.
1.７ Immunocytochemistry and Histological Analysis
The cochlea whole mount was stained with Pro⁃
pedium Iodide（PI Sigma）, a DNA specific labling
agent, and then examined using a Radiance2100
con-focal fluorescence microscope（Bio-Rad com⁃
pany）located at the Academy of Military Medical
Sciences.
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1.8 Statistical analysis The SPSS statistical soft⁃
ware package was used. All values are given as
means ± SD. Comparisons were made using the
student’s t-test .
２ Results
２.１ ABR threshold There was no significant dif⁃
ference in ABR thresholds between the inoculated
and contralateral ears, or between the experiment
and control groups at 5 days post surgery（P >
0.05）; ABR thresholds at 5 days post surgery were
not significantly different from those before the
surgery for both the inoculated and the contralater⁃
al ears（P>0.05）.
２.２ Gross examination of the ear At 5 and 14
days post-surgery, the middle ear cavity was
found clean with no signs of inflammation or hem⁃
orrhage in either the middle ear or inner ear.
Round window membrane was also clean, free of
hyperaemia. Small amount of exudation was visi⁃
ble in the round window niche in animals exam⁃
ined at 5 days post-surgery, but not in those exam⁃
ined at 14 days post-surgery.
２.3 Hath1 expression in cochlea Under the fluores⁃
cence microscope, bright green fluorescent light
（representative of gene expression）was seen in
cochleae with inoculation. Green fluorescent was
visible throughout the cochlea, from the basal turn
to apical turn（Fig.2a-d）. The high levels of fluores⁃
cent light were seen 5 days after the surgery, and
showed little decrease in intensity in animals ex⁃
amined on day 14. The Hath1 expression was fo⁃
cused in the supporting cell area invoving the in⁃
ner sulcus cell（IS）and spiral ganglion cell(SGC).
It was also seen in epithelial cells in the scalae tym⁃
pani and vestibule（Fig.2e）. Hath1 expression was
not detected in the non-inoculated ear or ears in
the control group（Fig.2f）. PI after staining re⁃
vealed punctiform absence of outer hair cells in in⁃
oculated ears（Fig.2g）, but not in inner and outer
hair cells of the control group.
３ Discussion
Cochlear gene transfer studies in animal models
have utilized mainly two methods: direct injection
through the round window membrane（RWM）or
intracochlear infusion through a cochleostomy.
However, structural damage from surgical trauma
and inflammatory reaction and hearing loss associ⁃
ated with these methods lead us to search for a
less invasive delivery method. Another concern is
injury to adjacent important structures caused by
surgical maneuvers, which has restricted its appli⁃
cation 5, 6. An alternative technique in gene transfer
is through the cerebrospinal fluid and the induc⁃
tion is achieved via the cochlear aqueduct to reach
both inner ears. However, animal studies show
that expression of target genes in the cochlea, lim⁃
ited by the number of receptors, is mainly distribut⁃
ed in basal turns bilaterally. Expression is also
seen in the bottom part of the brain, raising the
question of a potential risk to the brain . These
have restricted clinical application of such tech⁃
niques 7.
Based on the understanding of anatomical charac⁃
teristics of the cochlea and biological features of
the RWM as a semipermeable membrane with con⁃
siderable permeability 8, we introduced a new and
minimal invasive gene delivery technique, which in⁃
volves delivery of Ad-Hath1-EGFP into the round
window niche and its penetration of the RWM into
the cochlea. The advantages of this technique in⁃
clude minimal disturbances to cochlear structural
integrity and no risk of lymphatic leakage or liquid
extravasation from RWM［9, 10］. The surgical ap⁃
proach in this technique is simple and allows pres⁃
Figure1 Inoculated ears in experiment group
Figure2 Contralateral ears in experiment group
Figure 3 Inoculated ears in control group
Figure 4 Contralateral ears in control group
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ervation of normal physiological functions of the
cochlea. Examinatgion of the middle ear cavity at
5 and 14 days post-surgery in this study showed
no signs of inflammatory reaction or hemorrhage
in either the middle ear or inner ear. There was no
significant difference in ABR threshold before and
after the surgery or between the experiment and
control groups(P > 0.05), suggesting no influence
on hearing by the surgical maneuvers. Punctiform
loss of outer hair cells seen only in inoculated ears
may be indicative of injury to adjacent hair cells
from viral biotoxicity, which seems to have little ef⁃
fects on auditory function.
The carrier employed in this study, i.e. AD virus,
Figure 2 AD virus-mediated Hath1-EGFP gene expression in cochlea. a-d. Hath1-EGFP expression in supporting
cells next to inner sulcus cell(IS) and spiral ganglion cell (SGC); e. expression in epithelial cells of scala tympani and
scala vestibuli; f. Absence of Hath1-EGFP expression in the control group; g.punctiform loss of OHC (↑).
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has a high transfection efficiency（possibly 100%）,
capable of infecting both dividing and nondividing
cells. It is easy to culture and purify and can be
prepared at high titres. Its unconformity with host
cell genome makes it a relative safe carrier, with a
bright future of application 11, 12. Our data show that
the target gene was widely expressed in the co⁃
chlea at 5 days after the surgery, involving the sup⁃
porting cells and spiral ganglion cells. There was a
gradual decrease in the intensity of fluorescent
light from the basilar turn to the top turn, suggest⁃
ing that the target gene carried by AD virus was
disperse throughout the whole cochlear area via in⁃
ner ear lymph fluid, with relatively high expres⁃
sion in the region adjacent to injection compared
to other areas. The difference in target gene ex⁃
pression in the cochlea may be due to relatively
slow circulation metabolism of inner ear lymph flu⁃
id or the inability of the defective AD virus to
cross the labyrinth membrane between the inner
and outer spatium perilymphaticum. In addition,
the tropism of the virus towards the tissue cell is
determined by the virus receptors in the tissues. Vi⁃
rus adhesion towards tissue cells usually takes sev⁃
eral to dozens of minutes, which is influenced not
only by the virus adhesion protein, the electrifica⁃
tion condition and cellular structure of the specif⁃
ic cell receptor, but also by various environmental
factors including humidity, presence of ions, pH
value and route of viral invasion 13.
The minimal change in fluorescent light intensity
between day 5 and day 14 day indicates gene ex⁃
pression stability. However, abundant early and
late protein production following virus injection of
virus can cause host immune reaction and subse⁃
quent clearance, which can limit expression peri⁃
od. By combining recombinated AD virus and im⁃
mune depressant, some researchers have been
able to prolong the expression period 14. Further in⁃
vestigation is needed to achieve long-term expres⁃
sion of exogenous gene carried by AD virus.
Safe drug administration via appropriate route is
especially important in treating inner ear dis⁃
eases15. The technique used in the present study is
easy, atraumatic, and effective in delivering trans⁃
genes through intact RWM. Compared with other
more invasive gene delivery methods, this tech⁃
nique represents a safer and more clinically viable
route of cochlear gene delivery. The technique at
its present form needs further improvements. Audi⁃
tory thresholds need to be systematically tested at
more time points and at different frequencies. Spa⁃
tial and temporal characteristics of gene expres⁃
sion in the inner ear with hearing damage induced
by drug or noise need to be studied and gene trans⁃
duction efficiency need to be quantified.
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